References

  1. UNAIDS: Report on the Global AIDS Epidemic 2012 (http://www.unaids.org/media/unaids/content/epidemiology/2012/gr2012/201)

  2. Tanzania HIV/AIDS and Malaria Indicator Survey (THMIS) 2011- 2012 (http://www.tacaids.go.tz/component/docman/doc_details/73-third-tanzania-hiv-and-malaria-indic..). Google Scholar

  3. NACP: Epidemiology of HIV/AIDS. NATIONAL GUIDELINES FOR THE MANAGEMENT OF HIV AND AIDS.Fourth Edition. Ministry of Health and Social Welfare Tanzania; 2012:1-2. Google Scholar

  4. TACAIDS:United Republic of Tanzania, COUNTRY PROGRESS REPORT: Part A: Tanzania Mainland 2012 (http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/2012countrie…)

  5. Conaldi PG, Biancone L, Botelli A, Wade-Evans A, Racusen LC, Boccelino M, Orland V, Serra C, Camussi G, Toniolo A. HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation. J Clin Invest. 1998;102(12):2041–9. PubMed | Google Scholar

  6. Bruggeman L, Bark C, Kalayjian RC. HIV and the Kidney. Curr Infect Dis Rep. 2009;11(6):479–485. PubMed | Google Scholar

  7. Husain M, Gusella GL, Klotman ME, Gelman IH, Ross MD, Schwartz EJ, Cara A, Klotman PE. HIV-1 Nef Induces Proliferation and Anchorage-Independent Growth in Podocytes. J Am Soc Nephrol. 2002;13(7):1806–1815. PubMed | Google Scholar

  8. Ray PE, Hu CA. Advances in our understanding of the pathogenesis of HIV-1 associated nephropathy in children. Future Virol. 2011;6(7):883–894. PubMed | Google Scholar

  9. Kiryluk K, Martino J, Gharavi AG: Genetic Susceptibility, HIV Infection, and the Kidney. Clin J Am Soc Nephrol. Clin J Am Soc Nephrol. 2007 Jul;2 Suppl 1:S25-35. PubMed | Google Scholar

  10. Satko SG, Freedman BI, Moossavi S. Genetic factors in end-stage renal disease. Kidney international. 2005;67( Suppl 94):S46–9. PubMed | Google Scholar

  11. Freedman BI, Murea M. Potential effects of MYH9-associated nephropathy on dialysis and kidney transplant outcomes. Semin Dial. 2010;23(3):244–247. PubMed | Google Scholar

  12. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, knob ALU, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR. Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans. Science. 2010 Aug 13;329(5993):841-5. PubMed | Google Scholar

  13. Quaggin SE. Genetic susceptibility to HIV-associated nephropathy. J Clin Invest. 2009 May;119(5):1085-9. PubMed | Google Scholar

  14. Chow KM, Wong TYH, Li PK.Genetics of common progressive renal disease. Kidney international. Supplement 2005;67(94):S41–5. PubMed | Google Scholar

  15. Kopp JB, Winkler CA, Nelson GW. MYH9 Genetic Variants Associated With Glomerular Disease: What Is the Role of Genetic Testing? Semin Nephrol. 2010; 30(4):409–417. PubMed | Google Scholar

  16. Koroshi A. Microalbuminuria , is it so important? Hippokratia. 2007;11(3):105–107. PubMed | Google Scholar

  17. De Zeeuw D. Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment? Kidney international. 2004;66(Suppl 92):2–6. PubMed | Google Scholar

  18. Choi AI, O'Hare AM, Rodriguez R. Update on HIV-associated Nephropathy. Nephrology Rounds 2007, 5(September). Google Scholar

  19. Szczech LA, Grunfeld C,Schezer R, Canchola JA, van der Horst C, Sidney S, Wohl D, Shlipak MG. Microalbuminuria in HIV infection. AIDS. 2007 May 11;21(8):1003-9. PubMed | Google Scholar

  20. Szczech LA, Hoover DR, Feldman JG, Cohen MH ,Gange SJ, Gooze L, Rubin NR, Young MA, Cai X, Shi Q, Gao W, Anastos K. Association between Renal Disease and Outcomes among HIV-Infected Women Receiving or Not Receiving Antiretroviral Therapy. HIV/AIDS CID. 2004;39:1199–1206. PubMed | Google Scholar

  21. Kim PS, Woods C, Dutcher L, Georgoff P, Rosenberg A, Mican JAM, Kopp JB, Smith MA, Hadigan C. Increased Prevalence of Albuminuria in HIV-Infected Adults with Diabetes. PLos One. 2011;6(9):e24610. PubMed | Google Scholar

  22. Han TM, Naicker S, Ramdial PK, Assounga GK. A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney International. 2006 Jun;69(12):2243-50. PubMed | Google Scholar

  23. Fabian J,Naicker S, Venter W, Baker L, Naidoo S, Paget G, Wadee S. Urinary screening abnormalities in antiretroviral-naive HIV-infected outpatients and implications for management- A single –center study in South Africa. Ethn Dis. 2009 Spring;19(1 Suppl 1):S1-80-5. PubMed | Google Scholar

  24. Eke FU, Anochie IC, Okpere AN, Eneh AU, Ugwu RN, Ejilemele AA, Ugboma HU. Microalbuminuria in children with human immunodeficiency(HIV) infection in Port Harcourt, Nigeria. Nigeria J Med. 2010;19(3):298-301. PubMed | Google Scholar

  25. Msango L, Downs JA, Kalluvya SE, Kidenya BR, Kabangila R, Johnson WD, Fitzgerald DW, Peck RN. Renal dysfunction among HIV-infected patients starting antiretroviral therapy. AIDS. 2011;25(11):1421-1425. PubMed | Google Scholar

  26. Fredrick F, Ruggajo P, Maro E, Iversen BM, Basu G. Renal manifestation and associated factors among HIV infected children at Muhimbili National Hospital, Dar-es- Salaam, Tanzania. BMC Infectious Diseases. 2012;12(Suppl 1):011. PubMed | Google Scholar

  27. Uzoma BE, Uchena OH, Nnaemeka IA, Tagbo O. Screening for Microalbuminuria in HIV-Positive Children in Enugu. International Journal of Nephrology. 2012;2012:805834. PubMed | Google Scholar

  28. Parikh CR, Fischer MJ, Estacio R, Schrier RW. Rapid microalbuminuria screening in type 2 diabetes mellitus: simplified approach with Micral test strips and specific gravity. Nephrol Dial Transplant. 2004;19(7):1881–5. PubMed | Google Scholar

  29. African Network for the Care of Children affected by AIDS (ANECCA). Epidemiology, Pathogenesis and Natural History. Handbook on Paediatric AIDS in Africa. Edited by Tindyebwa D,Kayita J, Musoke P, Eley B, Nduati R, Coovadia H, Bobart R, Mbori-Ngacha D, Kiefer MP. Kampala Uganda;2004: 17-31. PubMed | Google Scholar

  30. Chaparro AI, Mitchell CD, Abitbol CL, Wilkinson JD, Baldarrago G, Lopez E, Zilleruelo G. Proteinuria in Children Infected with the Human Immunodeficiency Virus. Pediatrics. 2008 Jun;152(6):844-9. PubMed | Google Scholar

  31. Ekulu PM, Nseka NM, Aloni MN, Gini JL, Makulo JR, Lepira FB, Sumaili EK, Mafuta EM, Nsibu CN, Shiku JD. Prevalence of proteinuria and its association with HIV / AIDS in Congolese children living in Kinshasa , Democratic Republic of Congo [abstract]. Nephrol Ther. 2012;8(3):163–67. PubMed | Google Scholar

  32. Ramezani A, Mohraz M, Banifazl M, Jam S, Gachkar L, Yaghmaie F, Eslamifar A, Zadsar M, Kalantar N, Nemati K, Haghighi M, Rezaie M, Aghakhani A. Frequency and associated factors of proteinuria in Iranian HIV-positive patients. International Journal of Infectious Diseases. 2008 Sep;12(5):490-4. PubMed | Google Scholar

  33. Iduoriyekemwen NJ, Sadoh WE, Sadoh AE. Prevalence of Renal Disease in nigerian Children Infected with the Human Immunodeficiency Virus and on Highly Active Anti-retroviral Therapy. Saudi J Kidney Dis Transpl. 2013;24(1): 172-173. PubMed | Google Scholar

  34. Elewa U, Sandri AM, Rizza SA, Fervenza FC.Treatment of HIV-associated nephropathies. Nephron Clinical practice. 2011;118(4):346–54. PubMed | Google Scholar